Acceptable respondent burden in patient-reported outcome (PRO) assessment in oncology clinical trials: a mixed methods study with patients and trialists

Table 5 Survey participant responses to statements on the value of PROs in oncology trials

Survey questions	Strongly agree N (%)	Agree N (%)	Disagree N (%)	Strongly disagree N (%)	I don’t know or have an opinion N (%)
PRO questionnaires can help me express how I feel and function whilst participating in a clinical trial	46 (51%)	37 (41%)	5 (6%)	0 (0%)	2 (2%)
PRO questionnaires are important to demonstrate the patient perspective, and they should be included as standard in clinical trials	54 (60%)	29 (32%)	2 (2%)	0 (0%)	5 (5%)